The report provides a detailed analysis essential for establishing an Epirubicin production plant. It encompasses all critical aspects necessary for Epirubicin production, including the cost of Epirubicin production, Epirubicin plant cost, Epirubicin production costs, and the overall Epirubicin production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating an Epirubicin production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Epirubicin is primarily used in the pharmaceutical industry as a chemotherapy drug to treat various cancers, including breast, ovarian, gastric, lung cancers, and lymphomas. It acts as an anthracycline antibiotic by inhibiting the enzyme topoisomerase II, leading to DNA damage and cancer cell death. Epirubicin is favoured for its potent antitumor activity combined with reduced side effects compared to similar drugs like doxorubicin. It is widely used as adjuvant therapy after surgery, especially in breast cancer, and in combination chemotherapy regimens for other cancers. Additionally, Epirubicin is used intravesically to prevent bladder cancer recurrence after surgery.
The epirubicin market is primarily driven by the rising global incidence of cancer, especially breast, ovarian, and lung cancers, where Epirubicin plays an important role in chemotherapy regimens. The global rise in patient awareness and improved healthcare infrastructure, especially in emerging markets like the Asia-Pacific, contributes significantly to market growth.
Advancements in drug formulations and delivery systems aimed at enhancing efficacy and reducing side effects further boost the demand. Additionally, regulatory support and ongoing R&D for new indications and better therapies also propel the market. However, factors such as high production costs and competition from targeted therapies and immunotherapies, which impact industrial epirubicin procurement. Moreover, geographic variations in healthcare infrastructure and cancer treatment protocols also affect procurement volumes and preferences, with higher demand in developed regions and growing markets in the Asia-Pacific.
Raw Material for Epirubicin Production
According to the Epirubicin production plant project report, the raw material for Epirubicin production includes 13 daunorubicinol.
Production Process of Epirubicin
The extensive Epirubicin production cost report consists of the following major industrial production process:
- Production from 13 daunorubicinol: The production process of Epirubicin involves the conversion of 13 daunorubicinol to Epirubicin by first protecting the glycosidic amine as N trifluoroacetyl 13 daunorubicinol, then performing an activated DMSO/acylating agent oxidation to form 4′ keto N TFA daunorubicin (with concurrent 13 keto). The reaction is followed by a stereoselective borohydride reduction to set the 4′ epi configuration, basic hydrolysis to deprotect the amine, C 14 halogenation to give a 14 Hal intermediate, and final hydrolysis in the presence of an alkali metal formate to produce Epirubicin.
Properties of Epirubicin
Epirubicin is a 4'-epi-isomer of doxorubicin with molecular formula C27H29NO11 and molecular weight around 543.5 g/mol. It appears as an orange-red crystalline powder. Epirubicin is soluble in water (93 mg/L at 25 degree Celsius), DMSO, and ethanol. It has multiple ionizable groups, resulting in several pKa values: phenol (~9.17), amine (~9.93), and hydroxyl (~12.67). The compound has a melting point of 344.5 degree Celsius and a boiling point estimated near 810 degree Celsius at standard pressure. It is a strong binder to plasma proteins (~77%) and distributes extensively into tissues, indicated by a high volume of distribution. Due to its chemical structure, Epirubicin belongs to the aminoglycosides, tetracene quinones, and p-quinones classes. It shows stability with a documented shelf life of weeks to months in aqueous solutions at refrigerated and room temperatures.